29.04.09 Belgian Ablynx NV (Ghent) will enter Phase II clinical testing with its anticoagulant bivalent antibody fragment ALX-0081, after a Phase Ib study with 19 volunteers suggested complete inhibition of its target, the van Willebrand...
more
20.11.08 Paris/Gosselies – Biotech cluster Lyonbiopôle in the Rhône-Alpes region and Biowin, which is based in the French-speaking part of Belgium, have laid the foundations for a transborder cluster. “From the outset, we wanted to adopt...
more
15.10.08 Brussels – The 21 research groups and five SMEs that make up the new EU-funded LipidomicNet project have launched a knowledge platform on Wikipedia (www.lipidomicnet.org). The novel resource, which will be regularly updated by...
more
20.05.08 Brussels – Unprocessed grains of Syngenta’s herbicide-tolerant biotech maize GA21 have been approved for use in the European Union for an initial period of 10 years, according to a European Commission decision. The genetically...
more
20.05.08 Brussels – To ensure that new genetic tests become available to patients, European human geneticists have called for a ban on patents covering disease genes and related SNPs. Additionally, the group under Prof. Gert Matthijs...
more
